Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Growth in Domestic Violence Incidents Shows Opportunity for SuperCom Ltd. (NASDAQ: SPCB) Electronic Monitoring Suite

A report by news magazine Caribbean National Weekly (Law Alone Will Not Curb Domestic Violence) this month highlighted the growing incidents of domestic violence both in the Caribbean and in the United States, and how laws alone are not enough (https://ibn.fm/D4yI1). “What law can effectively prevent people from trying to control others, control where they […]

SenesTech Inc. (NASDAQ: SNES) Marks Entry into One of the Largest Pest Control Markets with Fruit Tree Limited’s Distribution Deal

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just marked its entry into Hong Kong and Macau, with potential expansion into Mainland China. This move positions the company in one of the largest pest control markets globally, made possible through its distribution […]

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) Signs New Agreement with Advanced Vision Smart Solutions in the United Arab Emirates for Platform Distribution

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0), a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications, recently announced the signing of a major distribution agreement with a distributor in the United Arab Emirates (“UAE”) to distribute the entire Sekur private and encrypted communications platform. The agreement is the […]

Correlate Energy Corp. (CIPI) Bolsters its C-Suite Team and Board of Directors with Three New Appointments; Optimistic About Continued Growth and Success

Correlate Energy (OTCQB: CIPI), a publicly traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation, has announced notable additions to its c-suite team, as well as its board of directors. This follows the successful close of the 2023 calendar year and the commencement of what is set to be the […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Expedite Human and Animal Studies on DehydraTECH’s Effectiveness on GLP-1 Drugs Following Positive Results from Pilot Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The drug […]

InvestorBrandNetwork Highlights PaxMedica Inc.’s (NASDAQ: PXMD) Video Release on Transformative ASD Study

In a significant development for the neurological disorder community, PaxMedica (NASDAQ: PXMD) has released an insightful video detailing the outcomes of its Phase 2 study on Autism Spectrum Disorder (“ASD”), initially published in the Annals of General Psychiatry. This pivotal video highlights the research led by Chief Medical Officer Dr. David Hough and a team […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Doubling Down on Separation and Refining of Critical Metals Amid China’s Ban on Export of Rare Earth Technology

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), engaged in the exploration for and separation and scalable production of rare earth elements (“REEs”) in Canada and the U.S., is looking to double down on its unique method of separation and refining of rare earth elements, an approach that it is confident will assert its market dominance, […]

 

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.